SRPT Earnings

Quarterly EPS
$0.35
Q3 2024
$1.65
Q4 2024
$-4.60
Q1 2025
$2.01
Q2 2025
$-1.80
Q3 2025
$-2.70
Q4 2025
$3.15
Q1 2026
$-0.05
Q2 2026
Latest Revenue401.3M
Latest Net Income-4890000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.05401.3M-4890000-34.3%-102.5%
Q1 2026$3.15730.8M331.0M-1.9%+168.5%
Q4 2025-$2.70442.9M-282847000-32.7%-263.6%
Q3 2025-$1.80399.4M-179947000-14.5%-614.3%
Q2 2025$2.01611.1M196.9M+68.4%+2,771.4%
Q1 2025-$4.60744.9M-447508000+80.2%-1,310.5%
Q4 2024$1.65658.4M159.0M+65.9%+275.0%
Q3 2024$0.35467.2M33.6M+40.8%+176.1%
Q2 2024$0.07362.9M6.5M
Q1 2024$0.38413.5M36.1M
Q4 2023$0.44396.8M45.7M
Q3 2023-$0.46331.8M-40937000
Sarepta Therapeutics, (SRPT) — Earnings